Article
Development of an isotoxic decision support system integrating genetic markers of toxicity for the implantation of a rectum spacer.
Acta oncologica (Stockholm, Sweden) - 1 Nov 2018
van Wijk Yvonka, Vanneste Ben G L, Jochems Arthur, Walsh Sean, Oberije Cary J, Pinkawa Michael, Ramaekers Bram L T, Vega Ana, Lambin Philippe
Abstract excerpt
INTRODUCTION: Previous studies revealed that dose escalated radiotherapy for prostate cancer patients leads to higher tumor control probabilities (TCP) but also to higher rectal toxicities. An isotoxic model was developed to maximize the given dose while controlling the toxicity level. This was applied to analyze the effect of an implantable rectum spacer (IRS) and extended with a genetic test of normal tissue...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
